Search results for: PhRMA

HTA in Japan: Failing to Meet International Good Practice?

15 March 2019

…a QALY-based system. It could lead the world in doing this. Funding declaration and disclaimer: Adrian Towse’s participation in the PhRMA press conference was funded by PhRMA. The views expressed…

Policy Options for Formulary Development in Middle-income Countries

1 January 2017

PhRMA commissioned OHE Consulting to explore options and recommend methods that could help middle-income countries efficiently and effectively identify medicines for formulary inclusion. This report presents a framework for developing…

Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study

1 January 2017

PhRMA commissioned OHE Consulting to explore options and recommend methods that could help middle-income countries efficiently and effectively identify medicines for formulary inclusion. In a previous publication we presented a…

OHE Academy

…Academy. This material was produced with financial support from PhRMA. The views expressed in these presentations are those of the speakers and do not necessarily reflect PhRMA’s views or positions….

New free educational program launched – Explaining the U.S. Inflation Reduction Act

9 May 2023

…Program, launched today at ISPOR 2023, with the support of PhRMA, to explain the key IRA provisions as they relate to pharmaceutical payment and coverage. Our aim is to promote…

Reconciling MCDA and Augmented Cost-Effectiveness Analysis: Do We Get the Same Decisions?

14 April 2021

…opportunity cost threshold is an equivalent method to the use of QALY-based ACEA. This work was funded by the Pharmaceutical Research and Manufacturers of America Foundation (PhRMA Foundation) via a…

The Inflation Reduction Act: Price negotiation underway for the first 10 drugs

29 November 2023

…Cole received no funding for this article, but has undertaken related work on the topic of the IRA with funding from PhRMA. References CMS, 2023. Medicare Drug Price Negotiation Program:…

CBO Doesn’t Capture The Real Impact of H.R. 3 on Innovation 

14 September 2021

…This baseline has been disputed. The 10-year average from 2011 was 41 and the median number estimated by the experts we surveyed in our recent study for PhRMA was 45….

OHE in the Spotlight: Summer 2011

22 September 2011

…that is being funded by PhRMA and EFPIA. HTA methods and practical application was the focus of three OHE activities over the summer.  At the HTAi Annual Meeting, Adrian Towse…